Kalvista Pharmaceuticals, Inc. · NASDAQ:KALV
Sweeny Nicole sold 1,862 Kalvista Pharmaceuticals, Inc. shares (Form 4)
Traded Apr 16 to Apr 17, 2026 · Filed Apr 20, 2026
From Apr 16 to Apr 17, 2026, Sweeny Nicole (Chief Commercial Officer) sold 1,862 Kalvista Pharmaceuticals, Inc. shares at US$20.22 for US$37,650, leaving 51,391 shares. Filed Apr 20, 2026 (Form 4).
- Sold
- 1,862 shares
- Price
- US$20.22
- Value
- US$37,650
- Holding after
- 51,391 shares
- Trading plan
- No
- Role
- Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 16, 2026 | Common Stock | Option exercise | 6,250 | 53,253 | Direct | |
| Apr 17, 2026 | Common Stock | Sale | 1,862 | US$20.22 | 51,391 | Direct |
Source
Related
- Kalvista Pharmaceuticals, Inc.
- Sweeny Nicole
- Kalvista Pharmaceuticals, Inc. shareholders
- Form 4 · Sweeny Nicole · Jun 11, 2026
- Form 4 · Sweeny Nicole · May 27, 2026
- Form 4 · Sweeny Nicole · May 26, 2026
- Schedule 13G/A · Tang Capital Management LLC · Aug 14, 2026
- Form 4 · Audhya Paul K. · Jun 11, 2026
- Form 4 · Palleiko Benjamin L · Jun 11, 2026
- Form 4 · Yea Christopher · Jun 11, 2026
- Form 4 · Piekos Brian · Jun 11, 2026